Search Results - "Marugán, I."

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA group by González, M., Barragán, E., Bolufer, P., Chillón, C., Colomer, D., Borstein, R., Calasanz, M. J., Gómez‐Casares, M. T., Villegas, A., Marugán, I., Román, J., Martín, G., Rayón, C., Debén, G., Tormo, M., Díaz‐Mediavilla, J., Esteve, J., González‐San Miguel, J., Rivas, C., Pérez‐Equiza, K., García‐Sanz, R., Capote, F. J., Ribera, J. M., Arias, J., León, A., Sanz, M. A.

“…Of 167 newly diagnosed acute promyelocytic leukaemia patients, 83 patients were long (L)‐form (50%), eight variable (V)‐form (5%) and 76 short (S)‐form (45%)…”
Get full text

Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD SCID mice by RAMIREZ, M, REGIDOR, C, MARUGAN, I, GARCIA-CONDE, J, BUEREN, J. A, FERNANDEZ, M. N

“…We have reported short periods of post transplant neutropenia in human patients co-transplanted with cord blood (CB) and low numbers of haploidentical…”
Get full text

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome by MARTINEZ-CLIMENT, J. A, COMES, A. M, GARCIA-CONDE, J, VIZCARRA, E, BENET, I, ARBONA, C, PROSPER, F, SOLANO, C, GARCIAC LAVEL, B, MARUGAN, I, LLUCH, A

“…We determined prospectively the incidence of chromosomal abnormalities in patients with high-risk breast cancer (HRBC) after high-dose chemotherapy (HDCT) and…”
Get full text

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED) by JUAN, O, LLUCH, A, DE PAZ, L, PROSPER, F, AZAGRA, P, MARUGAN, I, MARTINEZ-AGULLO, A, GARCIA-CONDE, J

“…One to 10% of women with metastatic breast cancer have a recurrence of their disease as an isolated lesion (local, regional, or distant) which may be treated…”
Get full text

Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization by SANCHEZ-IZQUIERDO, D, SIEBERT, R, SONOKI, T, LE BEAU, M. M, SCHLEGELBERGER, B, DYER, M. J. S, GARCIA-CONDE, J, MARTINEZ-CLIMENT, J. A, HARDER, L, MARUGAN, I, GOZZETTI, A, PRICE, H. P, GESK, S, HERNANDEZ-RIVAS, J. M, BENET, I, SOLE, F

“…Structural alterations in 3q27 affecting the BCL6 locus are among the most frequent changes in B-NHL. The aim of the present study was to establish an…”
Get full text

Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia by SARSOTTI, E, MARUGAN, I, BENET, I, TEROL, M. J, SANCHEZ-LZQUIERDO, D, TORMO, M, RUBIO-MOSCARDO, F, MARTINEZ-CLIMENT, J. A, GARCIA-CONDE, J

“…In B-cell chronic lymphocytic leukemia (B-CLL), somatic mutation of IgVH genes defines a subgroup with favorable prognosis, whereas the absence of IgVH…”
Get full text

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome by Terol, M. J., Tormo, M., Martinez-Climent, J. A., Marugan, I., Benet, I., Ferrandez, A., Teruel, A., Ferrer, R., García-Conde, J.

“…Background: High serum levels of soluble intercellular adhesion molecule-1(s-ICAM-1/s-CD54) have been associated with adverse clinical features and poor…”
Get full text

Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols by Bolufer, P, Lo Coco, F, Grimwade, D, Barragan, E, Diverio, D, Cassinat, B, Chomienne, C, Gonzalez, M, Colomer, D, Gomez, MT, Marugan, I, Roman, J, Delgado, MD, Garcia-Marco, JA, Bornstein, R, Vizmanos, JL, Martinez, B, Jansen, J, Villegas, A, de Blas, JM, Cabello, P, Sanz, MA

“…Laboratory of Molecular Biology, Department of Clinical Pathology, Hospital Universitario La Fe, Valencia, Spain. bolufer_pas@gva.es BACKGROUND AND OBJECTIVES:…”
Get full text

Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation by SOLANO, C, BADIA, B, LLUCH, A, MARUGAN, I, BENET, I, ARBONA, C, PROSPER, F, GARCIA-CONDE, J

“…The aim of this study was to determine whether the detection of CTC in the apheresis product contribute significantly to treatment failure of patients with…”
Get full text

Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemia by BOLUFER, P, BARRAGAN, E, GOMEZ, M. T, ANGUITA, E, DIVERIO, D, CHOMIENNE, C, BRIZ, M, SANZ, M. A, MARTIN, G, BORNSTEIN, R, COLOMER, D, DELGADO, M. D, GONZALEZ, M, MARUGAN, I, ROMAN, J

“…To standardize the results obtained in PML/RAR alpha RT-PCR detection by laboratories of hospitals involved in the Spanish Program for Treatment of…”
Get full text

Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12) by Martinez-Climent, J A, Vizcarra, E, Benet, I, Marugan, I, Terol, M J, Solano, C, Arbona, C, Tormo, M, Comes, A M, García-Conde, J

Get full text

Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC) by BENET, I, PROSPER, F, MARUGAN, I, LLUCH, A, ARBONA, C, CASTILLO, I, SOLANO, C, GARCIA-CONDE, J

“…We have determined the effect of delayed addition of G-CSF after chemotherapy on PBPC mobilization in a group of 30 patients with high risk breast cancer…”
Get full text

The effect of passive tactile stimulation in the brain activity of children with attention deficit by Soria-Claros, M, Serrano-Marugan, I, Quintero, J, Ortiz, T

“…The N200 and P300 evoked potentials have proved a useful tool in monitoring children with attention deficit disorder (ADD). To assess brain information…”
Get full text

Immune Reconstitution Of Regulatory T-Cells Following Autologous Hematopoietic Stem Cell Transplantation by Perez-Garcia, A, Cabezudo, E, Lopez-Jimenez, J, Marugan, I, Peralta, T, Arnan, M, Ramos-Oliva, P, Benet, I, Lopez, S, Mestre, M, Odriozola, J, Solano, C, Duarte, R.F

Get full text

Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features by Vizcarra, E, Martínez-Climent, J A, Benet, I, Marugan, I, Terol, M J, Prosper, F, Marco, J, Sanchez, D, Ferrandez, A, Tormo, M, Sarsotti, E, Ferrer, R, García, M, Ortuño, F, Montagud, M, García-Conde, J

“…Mantle cell leukemia (MCLeu) has been considered as a leukemic form of mantle cell lymphoma (MCL). However, the presence of certain features rarely observed in…”
Get more information

The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients by Ruiz, M A, Marugan, I, Estellés, A, Navarro, I, España, F, Alberola, V, San Juan, L, Aznar, J, Garcia-Conde, J

“…After the administration of cytostatic drugs, an increase in thromboembolic phenomena has been described in cancer patients. The authors studied the changes in…”
Get more information

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients by INSA, A, LLUCH, A, PROSPER, F, MARUGAN, I, MARTINEZ-AGULLO, A, GARCIA-CONDE, J

“…We have analyzed retrospectively 439 women with recurrent breast cancer, followed at a single institution, in order to define potential prognostic factors for…”
Get full text

Treatment of Stage I and II Hodgkin's Disease with NOVP (Mitoxantrone, Vincristine, Vinblastine, Prednisone) and Radiotherapy by Tormo, Mar, Terol, MarÍA Jose, Marugán, Isabel, Solano, Carlos, Benet, Isabel, Garcia-Conde, Javier

“…We investigated the effectiveness of a new treatment regimen termed NOVP in early Hodgkin's disease, which reportedly has lower toxicity. Thirty-four patients…”
Get full text

Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma by Martinez-Climent, Jose A., Vizcarra, Esperanza, Sanchez, Dolors, Blesa, David, Marugan, Isabel, Benet, Isabel, Sole, Françesc, Rubio-Moscardo, Francisca, Terol, Maria J., Climent, Joan, Sarsotti, Elena, Tormo, Mar, Andreu, Enrique, Salido, Marta, Ruiz, Maria A., Prosper, Felipe, Siebert, Reiner, Dyer, Martin J.S., Garcı́a-Conde, Javier

“…Patients with mantle cell lymphoma (MCL) may present with either nodal or leukemic disease. The molecular determinants underlying this different biologic…”
Get full text

C-erbB-2 expression and its relationship with ploidy, p53 abnormalities and epidermal growth factor receptor content in human non-small cell lung cancer by López-Guerrero, J.A., Bolufer-Gilabert, P., Vera-Sempere, F.J., Marugán de la Concha, I., Barragán-González, E.

“…This study attempts to clarify the role of c-erbB-2 overexpression in human non-small cell lung cancer (NSCLC) and relate it with the p53 alterations, DNA…”
Get full text